Based on the Curaleaf Holdings Inc. stock forecast from 2 analysts, the average analyst target price for Curaleaf Holdings Inc. is CAD 12.92 over the next 12 months. Curaleaf Holdings Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Curaleaf Holdings Inc. is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Curaleaf Holdings Inc.’s stock price was CAD 2.12. Curaleaf Holdings Inc.’s stock price has changed by -5.36% over the past week, -28.14% over the past month and -54.11% over the last year.
No recent analyst target price found for Curaleaf Holdings Inc.
No recent average analyst rating found for Curaleaf Holdings Inc.
Company Overview Curaleaf Holdings Inc.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York. Read Less
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which i...Read More
Frequently Asked Questions About Curaleaf Holdings Inc. (CURA:CA) Stock
Based on ratings from 2 analysts Curaleaf Holdings Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on CURA:CA's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for CURA:CA is CAD 12.92 over the next 12 months. The maximum analyst target price is CAD 17.5 while the minimum anlayst target price is CAD 3.75.
Unfortunately we do not have enough data on CURA:CA's stock to indicate if its overvalued.
The last closing price of CURA:CA's stock was CAD 2.12.
The most recent market capitalization for CURA:CA is CAD 1.83B.
Based on targets from 2 analysts, the average taret price for CURA:CA is projected at CAD 12.92 over the next 12 months.
This means that CURA:CA's stock price may go up by +509.28% over the next 12 months.
We can't find any ETFs which contains Curaleaf Holdings Inc.'s stock.
As per our most recent records Curaleaf Holdings Inc. has 5,650 Employees.
Curaleaf Holdings Inc.'s registered address is 420 Lexington Avenue, New York, NY, United States, 10170.
You can get more information about it from Curaleaf Holdings Inc.'s website at https://www.curaleaf.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Curaleaf Holdings Inc. (CURA:CA) Stock
Based on ratings from 2 analysts Curaleaf Holdings Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on CURA:CA's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for CURA:CA is CAD 12.92 over the next 12 months. The maximum analyst target price is CAD 17.5 while the minimum anlayst target price is CAD 3.75.
Unfortunately we do not have enough data on CURA:CA's stock to indicate if its overvalued.
The last closing price of CURA:CA's stock was CAD 2.12.
The most recent market capitalization for CURA:CA is CAD 1.83B.
Based on targets from 2 analysts, the average taret price for CURA:CA is projected at CAD 12.92 over the next 12 months.
This means that CURA:CA's stock price may go up by +509.28% over the next 12 months.
We can't find any ETFs which contains Curaleaf Holdings Inc.'s stock.
As per our most recent records Curaleaf Holdings Inc. has 5,650 Employees.
Curaleaf Holdings Inc.'s registered address is 420 Lexington Avenue, New York, NY, United States, 10170.
You can get more information about it from Curaleaf Holdings Inc.'s website at https://www.curaleaf.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CURA:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
